Diagnos Laboratorium Utama Tbk. vs Timah Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 43.4K 24h volume), while Timah Tbk. trades at Rp3,610 (market cap 26.07T, 31.38M 24h volume). The key difference: Timah Tbk. is far larger — about 84.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Timah Tbk. is more actively traded (31.38M versus 43.4K). Which is the better fit depends on your goals.
| DGNS | TINS | |
|---|---|---|
Market Cap | 308B | 26.07T |
Volume | 43.4K | 31.38M |
Lot | 434 | 313.79K |
Turnover | 9.79M | 112.41B |
Average Price | 225.57 | 3,582.45 |
Value | 9.79M | 112.41B |
Indicative Equilibrium Price | 230 | 3,510 |
Indicative Equilibrium Volume | 110 | 374 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Timah Tbk (Company) was officially establish by Imas Fatimah, SH by Notarial Deed No.1 dated 2 August 1976. The Company represents a merger of three Dutch Mining companies with operations in Indonesia. The Company’s registration statement in offer 50.330.000 new B class shares at par value of Rp. 500 per share in Indonesia was effective on 27 September 1995. In relation to the offering the new shares, the Government of the Republic of Indonesia also offered 125,825,000 B class shares which were represented by 12,582,500 GDR (each GDR representing 10 B class shares) to the public outside Indonesia. Gross profit for 1999 stand at Rp 751 billion, a figure 45% lower than that achieved in 1998, when gross profits reached Rp 1,362 billion.
Read more on TINS →